$59.03
0.050.08%
Last update: Oct 27, 4:42 PM
Arrowhead Pharmaceuticals Inc (ARWR) Stock Price, Quote, News & History
ARWRNASDAQ
Arrowhead Pharma shares Phase 1/2a data for ARO-MAPT, showing up to 85% tau reduction in central nervous system Alzheimer's disease trial.
You can purchase shares of Arrowhead Pharma (NASDAQ:ARWR) through any online brokerage.
Other companies in Arrowhead Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Arrowhead Pharma has a consensus price target of $89.28.
The stock price for Arrowhead Pharma (NASDAQ: ARWR) is $59.03 last updated October 27, 2026 at 4:42 PM EDT.
There are no upcoming dividends for Arrowhead Pharma.
Arrowhead Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Arrowhead Pharma.
Arrowhead Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies...
